Syncromune ® Inc., a clinical-stage biopharmaceutical company developing SYNC-T, an in situ personalized immunotherapy platform optimized for solid tumor cancers, today announced the appointment of ...

Benitec Biopharma (NASDAQ:BNTC) is looking to raise around $30M in gross proceeds via its securities offerings. The biotechnology company is selling 1,443,000 shares of its common stock (or pre-funded ...

AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa” or the "Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced its financial ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

Popular diabetes and weight-loss drugs known as GLP-1s are helping to boost the biopharma sector's return on investment this ...

Xponance Inc. grew its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 23.1% during the fourth ...

Clinical-stage biopharmaceutical company specializing in therapies for gastrointestinal diseases Entero Therapeutics (NASDAQ:ENTO) negotiated and signed a rescission agreement with 100% of the ...

PNC Financial Services Group Inc. lessened its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 8.9 ...

BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025BDC-3042 Phase 1 clinical trial fully enrolled the highest ...

Fortunately, the S&P 500 recovered to new all-time highs by August 2020 and is now up about 150% from its COVID lows.

By: Olivia vonNieda, VP and General Manager, McKesson Compile, and Veena Attivilli, Head of Customer Success, McKesson ...